82 related articles for article (PubMed ID: 3048728)
1. Treatment of infections in non-neutropenic patients with cancer, AIDS, or renal transplant using ciprofloxacin.
Maggiolo F; Bianchi W; Ohnmeiss H
Chemioterapia; 1988 Jun; 7(3):164-8. PubMed ID: 3048728
[TBL] [Abstract][Full Text] [Related]
2. Treatment of urinary tract infections with ciprofloxacin after renal transplantation.
Grekas D; Thanos V; Dioudis C; Alivanis P; Tourkantonis A
Int J Clin Pharmacol Ther Toxicol; 1993 Jun; 31(6):309-11. PubMed ID: 8335429
[TBL] [Abstract][Full Text] [Related]
3. [The efficacy and tolerance of Bay-o-9867 (ciprofloxacin) in the treatment of infections of the urinary tract and of the lower respiratory tract].
Quartieri F; Bolognesi S; Sconosciuto F
Recenti Prog Med; 1994 Feb; 85(2):96-100. PubMed ID: 8184195
[TBL] [Abstract][Full Text] [Related]
4. Oral ciprofloxacin treatment of infections in geriatric patients.
Yangco BG; Kenyon VS; Halkias KD; Bogel JA; Toney JF; Chmel H
Clin Ther; 1989; 11(4):503-10. PubMed ID: 2776166
[TBL] [Abstract][Full Text] [Related]
5. Short-course ciprofloxacin treatment of acute uncomplicated urinary tract infection in women. The minimum effective dose. The Urinary Tract Infection Study Group [corrected].
Iravani A; Tice AD; McCarty J; Sikes DH; Nolen T; Gallis HA; Whalen EP; Tosiello RL; Heyd A; Kowalsky SF
Arch Intern Med; 1995 Mar; 155(5):485-94. PubMed ID: 7864704
[TBL] [Abstract][Full Text] [Related]
6. Use of intravenous ciprofloxacin in difficult-to-treat infections.
Giamarellou H; Galanakis N
Am J Med; 1987 Apr; 82(4A):346-51. PubMed ID: 3555059
[TBL] [Abstract][Full Text] [Related]
7. Clinical experience with ciprofloxacin: analysis of a multicenter study.
Hays DJ; Fielder RL; O'Neal ET; Wright AC
J Ky Med Assoc; 1989 Oct; 87(10):506-9. PubMed ID: 2681482
[TBL] [Abstract][Full Text] [Related]
8. Clinical experience with ciprofloxacin.
Palmer JP; Barit MC; Powderly B; Velasquez BG
W V Med J; 1989 Jul; 85(7):280-2. PubMed ID: 2667259
[TBL] [Abstract][Full Text] [Related]
9. Clinical experience with ciprofloxacin.
Hann JR; Sudderth BF; Baker RV; Harrison RE
J Ark Med Soc; 1989 Sep; 86(4):156-8. PubMed ID: 2529246
[TBL] [Abstract][Full Text] [Related]
10. Oral ciprofloxacin in the treatment of elderly patients with complicated urinary tract infections due to trimethoprim/sulfamethoxazole-resistant bacteria.
Preheim LC; Cuevas TA; Roccaforte JS; Mellencamp MA; Bittner MJ
Am J Med; 1987 Apr; 82(4A):295-300. PubMed ID: 3555051
[TBL] [Abstract][Full Text] [Related]
11. [Peroral ciprofloxacin in the therapy of infections in oncology patients].
Krcméry V; Horníková M; Koza I; Fuchsberger P; Spánik S; Sufliarsky J; Mardiak J; Sitáni L; Milosovic P
Cas Lek Cesk; 1990 Oct; 129(42):1337-8. PubMed ID: 2257584
[TBL] [Abstract][Full Text] [Related]
12. Clinical experience with ciprofloxacin: analysis of a multicenter study.
Simmons JF; Cowley CE; Dozier DB; Galdini AM; Manes MR; Nungester GH; Schreeder MT; Strother KD; Chun BW
Ala Med; 1989 Feb; 58(8):10-3. PubMed ID: 2646874
[TBL] [Abstract][Full Text] [Related]
13. Clinical experience with ciprofloxacin: analysis of a multi-practice study.
Dunbar CP; Ashton RL; Atkinson L; Crotwell HF; Faris HM; Royal HG; Tyson DW; White CH
J S C Med Assoc; 1989 Mar; 85(3):97-101. PubMed ID: 2709819
[TBL] [Abstract][Full Text] [Related]
14. Clinical experience with ciprofloxacin: analysis of a multicenter study.
Hines CH; Bordelon JY; Jens DK; Le CV; McManus LJ; Spurlock WM
J La State Med Soc; 1989 Dec; 141(12):39-42. PubMed ID: 2691593
[TBL] [Abstract][Full Text] [Related]
15. Pentoxifylline, ciprofloxacin and prednisone failed to prevent transplant-related toxicities in bone marrow transplant recipients and were associated with an increased incidence of infectious complications.
Ferrà C; de Sanjosé S; Lastra CF; Martí F; Mariño EL; Sureda A; Brunet S; Gallardo D; Berlanga JJ; García J; Grañena A
Bone Marrow Transplant; 1997 Dec; 20(12):1075-80. PubMed ID: 9466281
[TBL] [Abstract][Full Text] [Related]
16. Ciprofloxacin versus cinoxacin in therapy of urinary tract infections. A randomized, double-blind trial.
Goldstein EJ; Kahn RM; Alpert ML; Ginsberg BP; Greenway FL; Citron DM
Am J Med; 1987 Apr; 82(4A):284-7. PubMed ID: 3555049
[TBL] [Abstract][Full Text] [Related]
17. Oral ciprofloxacin for treatment of severe infections.
Lobo IM; Silva NF; Assef MC; Mangini C; Silva ML; Bortoletto ML; Mendonça JS; Levi GC
Int J Clin Pharmacol Res; 1993; 13(2):81-5. PubMed ID: 8354593
[TBL] [Abstract][Full Text] [Related]
18. Sequential intravenous/oral ciprofloxacin as an empiric antimicrobial therapy: results of a Canadian multicenter study. The Canadian Collaborative Investigational Group.
Davis C
Clin Ther; 1994; 16(3):505-21. PubMed ID: 7923317
[TBL] [Abstract][Full Text] [Related]
19. Use of ciprofloxacin as a prophylactic agent in urinary tract infections in renal transplant recipients.
Moysés Neto M; Costa RS; Reis MA; Ferraz AS; Saber LT; Batista ME; Muglia V; Garcia TM; Figueiredo JF
Clin Transplant; 1997 Oct; 11(5 Pt 1):446-52. PubMed ID: 9361939
[TBL] [Abstract][Full Text] [Related]
20. Oral ciprofloxacin in resistant urinary tract infections.
Ryan JL; Berenson CS; Greco TP; Mangi RJ; Sims M; Thornton GF; Andriole VT
Am J Med; 1987 Apr; 82(4A):303-6. PubMed ID: 3555052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
